XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 6,057 $ 5,494 $ 17,945 $ 16,159
Cost of sales 2,205 1,977 6,508 5,893
Gross profit 3,852 3,517 11,437 10,266
Research, development and engineering expenses 410 377 1,222 1,108
Selling, general and administrative expenses 2,045 1,894 6,424 5,562
Amortization of intangible assets 189 159 543 467
Asset impairments 73 2 163 21
Total operating expenses 2,717 2,432 8,352 7,158
Operating income 1,135 1,085 3,085 3,108
Other income (expense), net (106) (42) (276) (144)
Earnings before income taxes 1,029 1,043 2,809 2,964
Income taxes 170 209 412 517
Net earnings $ 859 $ 834 $ 2,397 $ 2,447
Net earnings per share of common stock:        
Basic (in dollars per share) $ 2.25 $ 2.18 $ 6.27 $ 6.42
Diluted (in dollars per share) $ 2.22 $ 2.16 $ 6.20 $ 6.35
Weighted-average shares outstanding (in millions):        
Basic (in shares) 382.4 381.1 382.1 380.9
Effect of dilutive employee stock compensation (in shares) 4.3 4.5 4.4 4.5
Diluted (in shares) 386.7 385.6 386.5 385.4
Cash dividends declared per share of common stock (in dollars per share) $ 0.84 $ 0.80 $ 2.52 $ 2.40